Literature DB >> 15774995

Recent developments in inhaled therapy in stable chronic obstructive pulmonary disease.

C B Cooper1, D P Tashkin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15774995      PMCID： PMC554913          DOI： 10.1136/bmj.330.7492.640

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  25 in total

1.  Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium.

Authors:  J A van Noord; D R de Munck; T A Bantje; W C Hop; M L Akveld; A M Bommer
Journal:  Eur Respir J       Date:  2000-05       Impact factor: 16.671

Review 2.  A systematic review of the effects of bronchodilators on exercise capacity in patients with COPD.

Authors:  Jeroen J W Liesker; Peter J Wijkstra; Nick H T Ten Hacken; Gerard H Koëter; Dirkje S Postma; Huib A M Kerstjens
Journal:  Chest       Date:  2002-02       Impact factor: 9.410

3.  Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease.

Authors:  Donald A Mahler; Patrick Wire; Donald Horstman; Chai-Ni Chang; Julie Yates; Tracy Fischer; Tushar Shah
Journal:  Am J Respir Crit Care Med       Date:  2002-10-15       Impact factor: 21.405

Review 4.  Suboptimal medical therapy in COPD: exploring the causes and consequences.

Authors:  S D Ramsey
Journal:  Chest       Date:  2000-02       Impact factor: 9.410

5.  Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis.

Authors:  B J Lipworth
Journal:  Arch Intern Med       Date:  1999-05-10

6.  Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial.

Authors:  Peter Calverley; Romain Pauwels; Jørgen Vestbo; Paul Jones; Neil Pride; Amund Gulsvik; Julie Anderson; Claire Maden
Journal:  Lancet       Date:  2003-02-08       Impact factor: 79.321

7.  Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease.

Authors:  W Szafranski; A Cukier; A Ramirez; G Menga; R Sansores; S Nahabedian; S Peterson; H Olsson
Journal:  Eur Respir J       Date:  2003-01       Impact factor: 16.671

Review 8.  The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials.

Authors:  Abdullah Alsaeedi; Don D Sin; Finlay A McAlister
Journal:  Am J Med       Date:  2002-07       Impact factor: 4.965

9.  The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study.

Authors:  Keith L Hattotuwa; Mariusz J Gizycki; Tareq W Ansari; Peter K Jeffery; Neil C Barnes
Journal:  Am J Respir Crit Care Med       Date:  2002-06-15       Impact factor: 21.405

Review 10.  Therapy of chronic obstructive pulmonary disease.

Authors:  Peter J Barnes
Journal:  Pharmacol Ther       Date:  2003-01       Impact factor: 12.310
View more
  7 in total

1.  Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD.

Authors:  Shelley R Salpeter; Nicholas S Buckley; Edwin E Salpeter
Journal:  J Gen Intern Med       Date:  2006-10       Impact factor: 5.128

2.  Managing chronic diseases: combination of inhaler treatment in India has shown good results.

Authors:  Parvaiz A Koul
Journal:  BMJ       Date:  2005-04-23

Review 3.  Systematic review of clinical outcomes in chronic obstructive pulmonary disease: beta-agonist use compared with anticholinergics and inhaled corticosteroids.

Authors:  Shelley R Salpeter; Nicholas S Buckley
Journal:  Clin Rev Allergy Immunol       Date:  2006 Oct-Dec       Impact factor: 8.667

Review 4.  Long-acting beta2-agonists (LABA) in chronic obstructive pulmonary disease: efficacy and safety.

Authors:  Andrea Rossi; Sonia Khirani; Mario Cazzola
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

Review 5.  The development of anticholinergics in the management of COPD.

Authors:  Jane E Scullion
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

Review 6.  Review of ventilatory techniques to optimize mechanical ventilation in acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Raghu M Reddy; Kalpalatha K Guntupalli
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

Review 7.  Positioning new pharmacotherapies for COPD.

Authors:  Igor Z Barjaktarevic; Anthony F Arredondo; Christopher B Cooper
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-07-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.